Sign in to continue:

Saturday, February 21st, 2026

T-Mobile Announces Proposed Public Offering of Euro-Denominated Senior Notes for Corporate Purposes





T-Mobile Announces Proposed Public Offering of Euro-Denominated Senior Notes

T-Mobile Announces Proposed Public Offering of Euro-Denominated Senior Notes

Date: February 12, 2026

Location: Bellevue, Washington

Key Highlights

  • Public Offering Announcement: T-Mobile US, Inc. (NASDAQ: TMUS) has announced its intention to conduct a registered public offering of euro-denominated senior notes through its direct wholly-owned subsidiary, T-Mobile USA, Inc.
  • Use of Proceeds: The net proceeds from the offering will be used for general corporate purposes. These may include share repurchases, potential dividends declared by T-Mobile’s Board of Directors, and refinancing of existing indebtedness. This flexibility in use of proceeds could have direct implications for shareholders, especially regarding share buybacks or dividend distributions.
  • Joint Book-Running Managers: The offering will be managed by a consortium of leading international banks, including Barclays Bank PLC, BNP PARIBAS, Crédit Agricole Corporate and Investment Bank, Goldman Sachs & Co. LLC, and Morgan Stanley & Co. International plc.
  • Regulatory Filing: T-Mobile USA has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (SEC) for this offering. Investors are encouraged to review these documents for complete information.

Investor Information

  • Access to Offering Documents: The prospectus and related documents are available for free via the SEC’s EDGAR website. Alternatively, investors can request these documents from any of the book-running managers, whose contact details are provided in the announcement.
  • Distribution Restrictions: The offering is targeted specifically at eligible counterparties and professional clients under MiFID II and UK MiFIR product governance rules. No PRIIPs Key Information Document (KID) has been prepared, meaning the notes are not available to retail investors in the EEA or the UK.

Potential Price-Sensitive Information for Shareholders

  • Share Repurchases and Dividends: One of the potential uses for the proceeds is share repurchases and dividends. Either action could positively impact share value—repurchases may reduce share count and boost earnings per share, while dividends provide direct shareholder returns.
  • Debt Refinancing: The company may also use proceeds to refinance existing indebtedness, which could reduce interest expense and improve the overall financial health of T-Mobile, potentially increasing shareholder value.
  • Market Conditions: The offering is subject to prevailing market conditions and other factors. Investors should be aware that changes in market sentiment or unexpected developments could impact the timing, pricing, and ultimate execution of the offering.

Forward-Looking Statements and Risks

The announcement includes forward-looking statements regarding the planned offering and the intended use of proceeds. These statements are subject to risks, uncertainties, and assumptions—including market conditions and other factors. Actual results may differ materially from those anticipated. Shareholders should review T-Mobile’s filings with the SEC for detailed risk factors.

Contact Information



Disclaimer: This article summarizes information contained in T-Mobile’s official SEC filings and press releases. It contains forward-looking statements that are subject to risks and uncertainties. Investors should review the full SEC filings and consult their financial advisor before making any investment decisions. The information presented here does not constitute financial advice or a recommendation to buy or sell any securities.




View T-Mobile US, Inc. Historical chart here



REIN THERAPEUTICS, INC. 8-K Filing Details – Company Information, Address, Trading Symbol, and Regulatory Compliance (Feb 16, 2026)

Rein Therapeutics, Inc. Announces Resignation of Board Member – What Investors Need to Know Rein Therapeutics, Inc. (Nasdaq: RNTX), a pharmaceutical company headquartered in Austin, TX, has disclosed a significant change in its Board...

Rithm Capital Completes $1.8 Billion Acquisition of Paramount Group: Full Details and Pro Forma Financial Impact

Rithm Capital Completes \$1.8 Billion Acquisition of Paramount Group: Key Details for Investors Rithm Capital Completes \$1.8 Billion Acquisition of Paramount Group: What Investors Need to Know Overview of the Transaction On December 19,...

Service Corporation International (SCI) Declares Q1 2026 Cash Dividend and Provides Forward-Looking Statement

Service Corporation International Declares Quarterly Cash Dividend Key Highlights Quarterly Cash Dividend Announced: Service Corporation International (SCI), North America’s largest provider of deathcare products and services, has declared a quarterly cash dividend of \$0.34...

   Ad